Clinically validated to predict CRC recurrence.
COSMOS-CRC-01: 1,900+ TISSUE-FREE SAMPLES FROM 300+ PATIENTS WITH CRC
Home Screening MRD + Monitoring Treatment Selection
¶ In stage II or higher colon cancer.
# In stage II or higher colon cancer. Percentage is representative of longitudinal sensitivity.